Figures
Abstract
Smoking is considered a significant risk factor for both periodontal disease and cardiovascular disease (CVD). Endothelial cells play an important role in the progression of both diseases. In the present study, we investigated in vitro the impact of nicotine on functional properties of human umbilical vein endothelial cells (HUVECs) stimulated with lipopolysaccharide (LPS) of periodontal pathogen Porphyromonas gingivalis. HUVECs were stimulated with different concentrations of nicotine (10 µM-10 mM) and/or P. gingivalis LPS. Expression levels of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, monocyte chemoattractant protein 1, and interleukin-8 were measured on both gene and protein levels. Cell proliferation/viability, apoptosis, and migration were also investigated. Nicotine at a concentration of 10 mM significantly decreased P. gingivalis LPS-induced expression of all investigated proteins after 4 h stimulation, while lower nicotine concentrations had no significant effect on protein expression with or without P. gingivalis LPS. Proliferation/viability of HUVECs was also significantly inhibited by 10-mM nicotine but not by lower concentrations. Migration of HUVECs was significantly decreased by nicotine at concentrations of 1–10 mM. Nicotine at a concentration similar to that observed in the serum of smokers had no significant effect on the functional properties of HUVECs. However, high concentrations of nicotine, similar to that observed in the oral cavity of smokers, inhibited the inflammatory response of HUVECs. This effect of nicotine might be associated with decreased gingival bleeding indices in smoking periodontitis patients.
Citation: An N, Andrukhov O, Tang Y, Falkensammer F, Bantleon H-P, Ouyang X, et al. (2014) Effect of Nicotine and Porphyromonas gingivalis Lipopolysaccharide on Endothelial Cells In Vitro. PLoS ONE 9(5): e96942. https://doi.org/10.1371/journal.pone.0096942
Editor: Michael Glogauer, University of Toronto, Canada
Received: March 3, 2014; Accepted: April 13, 2014; Published: May 12, 2014
Copyright: © 2014 An et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Ministry of Science and Technology of China under contract International Science & Technology Cooperation Program Foundation Nr.1019. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Periodontitis is a chronic inflammatory disease which is caused by bacterial infection and leads to the destruction of periodontal tissues and resorption of alveolar bone. It is initiated by the accumulation of gram-negative bacteria in the dental biofilm [1]. Several gram-negative bacteria, such as Porphyromonas gingivalis (P. gingivalis), Treponema denticola, and Tannerella forsythia, are thought to be the primary etiological agents associated with periodontal disease [2]. Nowadays, it is widely accepted that there is an association between periodontal disease and cardiovascular disease (CVD), though no causative relationship between these diseases has been observed [3].
It is well recognized that tobacco smoking is a major risk factor for both periodontitis and CVD [3]. Smoking periodontitis patients exhibit greater bone loss, greater attachment loss, and deeper periodontal pockets than nonsmokers [4]. At the same time, smoking periodontitis patients have lower gingival bleeding indices compared to non-smoking patients, which is supposedly due to dysfunction of gingival vasculature [5], [6]. There is also strong evidence indicating that smoking causes injury to the vascular endothelium, leading to endothelial dysfunction and initiating the pathogenesis of atherosclerosis [7]–[9]. Thus, the impact of smoking on both periodontitis and CVD seems to be largely associated with its effect on endothelial cells (ECs). ECs underlie the inner surface of blood vessels and play an important role in the progression of both diseases. In particular, ECs are shown to mediate leukocyte infiltration into periodontal tissue during periodontitis [10], [11]. Endothelial dysfunction is considered to be the first inflammatory change of the vascular endothelium leading to arteriosclerosis [7]. The function of ECs in the inflammation process is associated with the production of several cytokines and adhesion molecules which regulate the migration of leukocytes toward the inflammatory area [12].
Nicotine is a major component of tobacco smoke and one of its most pharmacologically active agents. Park et al show that nicotine at concentrations similar to those found in habitual smokers does not induce any morphological changes in ECs but does enhance functional changes such as cellular proliferation, migration, and angiogenesis in vitro [13]. Heeschen et al suggest that nicotine enhances cellular proliferation, migration, and angiogenesis by stimulating nicotinic receptors in vascular ECs [14]. An in vitro study by Villablanca mentions that nicotine at concentrations observed in habitual smokers stimulates DNA synthesis and proliferation in vascular ECs, whereas higher nicotine concentrations might have cytotoxic effects [15]. Previous studies have also shown that the major periodontal pathogen P. gingivalis and/or its lipopolysaccharide (LPS) can activate the expression of adhesion molecules in ECs, which might then be involved in the progression of both periodontitis and CVD [16]–[18]. However, the influence of nicotine on the response of ECs to periodontal pathogens is still unknown. Therefore, in the present study, we investigated the influence of nicotine on cell proliferation, migration, and on the expression of several pro-inflammatory cytokines in ECs with and without stimulation with P. gingivalis LPS.
Materials and Methods
Cell culture
Commercially available human umbilical vein endothelial cells (HUVECs, Technoclone, Austria) were grown in endothelial cell medium (ECM) supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml fungizone, 2 mM L-glutamine, 5 U/ml heparin, 30–50 µg/ml endothelial cell growth supplement, and 20% fetal calf serum (FCS)¶. Cells were cultured in culture flasks coated with 0.2% gelatine at 37°C in a humidified atmosphere of 5% CO2 and 95% air. All experiments were performed using cells between the third and sixth passage and were repeated in triplicate.
Commercially available ultrapure P. gingivalis LPS (Invivogene, San Diego, CA, USA) was used in the present study. As reported by another study [19], LPS preparations were free from contaminating lipoproteins.
Cell proliferation/viability
MTT assay was used for determining cell proliferation/viability. For each experiment, 2×104 cells were added to each well in standard 24-well gelatin-coated tissue culture plates and stimulated with different concentrations of nicotine and/or P. gingivalis LPS. After incubation for 4 h, 24 h, 48 h, and 72 h, a 5 mg/ml concentration of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT solution, Sigma, St-Louis, USA) in PBS was added to each well, and culture plates were incubated at 37°C for 4 h. The medium was removed, and 500 µl dimethylsulfoxide (DMSO) was added to each well followed by a 5-min incubation on a shaker. Finally, 100 µl of each cultured solution was transferred to a separate 96-well plate, and the optical density (OD) was measured at 570 nm with an ELISA Reader (SpectraMax Plus 384, Molecular Devices, USA).
Production of pro-inflammatory mediators by HUVECs
HUVECs were seeded in gelatin-coated 6-well tissue culture plates at a density of 5×105 cells per well in 3 ml of ECM. After 24 h, the culture medium was replaced by ECM medium containing 5% FCS, and cells were stimulated with different concentrations of nicotine (10−5-10−2 M) in the presence or absence of P. gingivalis LPS (1 µg/ml) for 4–72 h. Non-stimulated cells were used as a negative control. After stimulation, the gene-expression levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, interleukin-8 (IL-8), and monocyte chemoattractant protein-1 (MCP-1) were analyzed by real-time PCR. In addition, the cell surface expression levels of ICAM-1, VCAM-1, and E-selectin as well as the quantities of IL-8 and MCP1 protein in conditioned media were analyzed by flow cytometry and ELISA, respectively.
Real-time PCR (qPCR) was performed as described previously [20]–[22]. Isolation of total cellular mRNA and its subsequent transcription into cDNA was performed using the TaqMan Gene Expression Cells-to-CT kit (Ambion/Applied Biosystems, Foster City, USA). Real-time PCR was performed on an Applied Biosystems Step One Plus real-time PCR system using TaqMan gene expression assays (all from Applied Biosystems, Foster City, USA) with the following ID numbers: ICAM-1: Hs00164932_m1, VCAM-1: Hs00365486_m1, E-selectin: Hs00174057_m1, IL-8: Hs00174103_m1, MCP-1: Hs00234140_m1. Triplicate qPCR reactions were prepared for each sample. During the reaction run, the point at which the PCR product was first detected above a fixed threshold (cycle threshold (CT)) was recorded for each sample. Data were presented as the relative amount of mRNA in one sample versus a control (fold change) using the formula 2(−ΔΔCT), meaning we used the difference between the CT of a gene of interest and the CT of the housekeeping gene GAPDH for one sample (ΔCT) and then compared this value to that of the calibrator (control) sample (ΔΔCT).
Analysis of the cell surface expression levels of adhesion molecules in HUVECs was performed using a flow cytometer (FACSCalibur, BD Bioscience, CA, USA) [21]. Cells were stained with one of the following monoclonal antibodies conjugated with phycoerythrin (all from eBioscience, San-Diego, CA, USA): mouse anti-human ICAM-1 antibody (Cat. Nr. 12-0549), mouse anti-human VCAM-1 antibody (Cat. Nr. 12-1069), mouse anti-human E-selectin antibody (Cat. Nr. 12-0627), and isotype control antibody (Cat. Nr. 12-4714). Cell counting was limited by 10,000 events.
Commercially available ELISA kits (Hoelzel Diagnostika, Cologne, Germany) were used for measurements of IL-8 (Cat. Nr. 950050192) and MCP-1 (Cat. Nr. BOS-EK0441) levels in the conditioned medium. The samples were diluted by a ratio of 1∶20 and 1∶5 for the measurements of IL-8 and MCP-1, respectively.
Quantification of apoptosis in HUVECs by flow cytometry
HUVECs were seeded in 6-well plates and stimulated with nicotine as described above for 4-72 h. After incubation, apoptosis was detected using the Annexin V-FITC Apoptosis Detection Kit I (BD Biosciences, San Jose, CA) according to the manufacturer's protocol. Cells were stained with both annexin V and propidium iodide to detect early and late apoptosis, respectively. The cells were washed twice after staining and acquired by a flow cytometer (FACSCalibur, BD Bioscience, CA, USA). Cell counting was limited by 10,000 events. The proportion of apoptotic and viable cells was quantified using CellQuest Software (BD Bioscience, CA, USA). The standard error of the mean was calculated from four independent trials.
Migration assay
Cell migration was assessed in a 48-well microchemotaxis chamber (Neuroprobe, Gaithersburg, MD, USA) on a polycarbonate filter with 8-µm pore size, as described previously [23]. The chamber consisted of acrylic top and bottom plates, each containing 48 matched wells. Top and bottom plates were separated by a polycarbonate filter with 8-µm pore size (Neuroprobe, Gaithersburg, MD, USA). Twenty-six microliters of serum-free medium containing different concentrations of nicotine and/or P. gingivalis LPS were filled in wells of the bottom plate. Subsequently, the bottom plate was covered with a filter, and the top plate was applied so that each well corresponded to that of the bottom plate. A cell suspension containing 1×104 cells in 50 µL of serum-free medium was added to each well of the top plate, and the whole chamber was incubated at 37°C in humidified air with 5% CO2 for 8 h. After incubation, cells on the upper surface of the filter were removed over the wiper blade, and the filters were then fixed with methanol and stained with Hemacolor for microscopy (Merck, Darmstadt, Germany). The cells that migrated across the filter were counted under a light microscope at high-power magnification (x100) to measure transmigration in each well. Four fields were counted in each well, and the total number was calculated. Four wells were used for each group, and experiments were repeated in triplicate.
Statistical analysis
All experiments were performed in triplicate. A one-way analysis of variance (ANOVA) with Tukey's HSD test was performed to assess the significance. Values of p<0.05 were considered statistically significant. All data analysis was performed using specific software (SPSS 19.0, SPSS Inc., Chicago, IL, USA).
Results
Effect of nicotine and P. gingivalis LPS on proliferation/viability of HUVECs
The effect of nicotine at concentrations of 10 µM-10 mM on the proliferation/viability of HUVECs in the presence or absence of P. gingivalis LPS, as measured by MTT assay after 4, 24, 48, and 72 h of stimulation, is shown in Figure 1. Nicotine at a concentration of 10 mM significantly inhibited proliferation/viability of HUVECs after 4 h of stimulation. Microscopic observation revealed that after stimulation with 10-mM nicotine for 24–72 h, most cells were detached from the well bottom, and therefore no parameters were measured in these groups. No significant effects were observed at nicotine concentrations of 10 µM-1 mM for any of the stimulation time points. In all groups, except those stimulated with 10-mM nicotine, the proliferation/viability continuously increased with time. P. gingivalis LPS at a concentration of 1 µg/ml did not affect the proliferation/viability of HUVECs at any of the stimulation time points.
HUVECs were stimulated with nicotine (10 µM-10 mM) and/or P. gingivalis LPS, and the proliferation/viability was measured after 4, 24, 48, and 72 h using the MTT assay. The y-axis represents mean ±SD values of optical densities measured at 450 nm from four wells of one representative experiment. * – significantly lower compared to control group, p<0.05.
Figure 2 shows the proportion of viable cells after stimulation with different nicotine concentrations and/or P. gingivalis LPS for 4, 24, and 72 h. Viable cells were determined as those which were negative for annexin V and propidium iodide. The proportion of viable cells was not affected by nicotine at concentrations of 10 µM-1 mM at any of the stimulation time points. This was true both in the presence and in the absence of P. gingivalis LPS. After 4 h of stimulation with 10-mM nicotine, the proportion of viable cells was significantly lower compared to that of the control group (p<0.05).
HUVECs were stimulated with nicotine (10 µM-10 mM) and/or P. gingivalis LPS, and the proportion of viable cells was measured using a flow cytometry apoptosis assay after 4 (A), 24 (B), and 72 (C) h. Viable cells were those negative for annexin V and propidium iodide. Data are presented as mean ±SD of three independent experiments. * – significantly lower compared to control group, p<0.05.
Effect of nicotine on the expression of pro-inflammatory mediators in HUVECs
Figure 3 shows the effect of nicotine on the mRNA expression levels of different pro-inflammatory mediators after stimulation for 4, 24, and 72 h. Nicotine at concentration of 10 µM-1 mM had no significant effect on the gene expression levels of ICAM-1 (Fig. 3A), VCAM-1 (Fig. 3B), E-selectin (Fig. 3C), MCP-1 (Fig. 3D), or IL-8 (Fig. 3E) at any of the stimulation time points. Similarly, no significant change in the expression of any of the pro-inflammatory mediators in HUVECs were observed after stimulation with 10-mM nicotine for 4 h.
HUVECs were stimulated with nicotine (10 µM-10 mM), and the expression levels of ICAM-1 (A), VCAM-1 (B), E-selectin (C), MCP-1 (D), and IL-8 (E) were measured by qPCR. GAPDH was used as endogenous control gene. Each value represents mean ±SEM of three independent assays. Non-stimulated HUVECs were used as a control ( = 1). The expression levels of pro-inflammatory mediators were not analyzed after stimulation with 10-mM nicotine for 24 and 72 h because the cells were not viable.
The effect of nicotine on the P. gingivalis LPS-induced mRNA and protein expression of pro-inflammatory mediators in HUVECs is shown in Figures 4 and 5, respectively. The largest increase in the mRNA expression levels of ICAM-1 (Fig. 4A), VCAM-1 (Fig. 4B), E-selectin (Fig. 4C), MCP-1 (Fig. 4D), and IL-8 (Fig.4E) was observed after 4 h of stimulation with 1 µg/ml of P. gingivalis, whereas the response was substantially diminished after 24 and 72 h of stimulation. Similarly, the largest surface expression levels of ICAM-1 (Fig. 5A), VCAM-1 (Fig. 5B), and E-selectin (Fig. 5C) were observed after 4 h of stimulation. The quantity of MCP-1 and IL-8 in conditioned media (Figs 5D and 5E, respectively) was continuously increased with stimulation time. Nicotine at a concentrations of 10 mM induced a significant decrease of P. gingivalis LPS-induced mRNA and protein expression levels of ICAM-1, VCAM-1, MCP-1, and IL-8 after 4 h of stimulation. P. gingivalis LPS-induced surface expression of E-selectin was significantly decreased by 10 mM after 4 h of stimulation, whereas the mRNA expression level of E-selectin was not affected. Nicotine at concentrations of 10 µM-1 mM had no significant effect on the P. gingivalis LPS-induced expression of pro-inflammatory mediators at any of the stimulation time points.
HUVECs were stimulated by P. gingivalis LPS in the presence or absence of nicotine (10 µM–10 mM), and the expression levels of ICAM-1 (A), VCAM-1 (B), E-selectin (C), MCP-1 (D), and IL-8 (E) were measured by qPCR after 4, 24, and 72 h. GAPDH was used as endogenous control gene. Each value represents mean ±SEM of three independent assays. Non-stimulated HUVECs were used as a control ( = 1). All proteins exhibited significantly higher mRNA expression levels after stimulation with P. gingivalis LPS compared to the control group (p<0.05). The expression levels of pro-inflammatory mediators were not analyzed after stimulation with 10-mM nicotine for 24 and 72 h because the cells were not viable. * – significantly different between groups, p<0.05.
HUVECs were stimulated by P. gingivalis LPS in the presence or absence of nicotine (10 µM–10 mM) for 4, 24, and 72 h. After stimulation, the surface expression levels of ICAM-1 (A), VCAM-1 (B), and E-selectin (C) were measured by flow cytometry, and the quantity of MCP-1 (D) and IL-8 (E) in conditioned media was measured by ELISA. Each value represents mean ±SD of three independent assays. Non-stimulated HUVECs were used as a control. The protein expression levels of pro-inflammatory mediators were not analyzed after stimulation with 10-mM nicotine for 24 and 72 h because the cells were not viable. * – significantly different between groups, p<0.05. † – significantly higher compared to controls, p<0.05.
Effect of nicotine on HUVEC migration
Figure 6 shows the number of HUVECs that migrated through the 8-µm polycarbonate membrane in the presence or absence of nicotine at concentrations of 10 µM-10 mM and/or P. gingivalis LPS. The number of migrated HUVECs was significantly decreased by nicotine at concentrations of 1–10 mM in a dose dependent manner (p<0.05). This was observed both in the presence and the absence of P. gingivalis LPS. P. gingivalis LPS induced a significant decrease in the number of migrated cells (p<0.05).
HUVEC migration through a polycarbonate membrane with pore size of 8 µm over 8 h was assessed in a 48-well microchemotaxis chamber. The y-axis represents mean ±SD of cells per microscope field of four different wells of one representative experiment. * – significantly different between groups, p<0.05.
Discussion
In the present in vitro study, we evaluated the effect of nicotine on EC properties under normal and inflammatory conditions. We found that nicotine at concentrations of 10 µM-1 mM had no effect on the proliferation/viability of HUVECs, as measured by MTT assay. At these nicotine concentrations, the proliferation/viability of HUVECs gradually increased with time, suggesting that cells proliferated during the observation period. However, 10-mM nicotine substantially inhibited the proliferation/viability of HUVECs after 4 h of stimulation; after stimulation for longer than 24 h, no viable cells were observed. Thus, it seems that 10-mM nicotine has a cytotoxic effect on HUVECs. Many previous studies also reported that nicotine at high concentrations inhibits EC proliferation and is cytotoxic. However, quantitative differences in estimating the toxicity of nicotine concentrations exist between studies. In particular, a recent study showed that the proliferation/viability of HUVECs is inhibited by nicotine at concentrations higher than 400 µg/ml (∼2.5 mM) [24], which is generally in agreement with our data. In contrast, another study showed that HUVEC proliferation measured by cell count is inhibited by as little as 0.1-µM nicotine [13]. A study on calf ECs showed that cell proliferation measured by DNA synthesis is inhibited by nicotine at concentrations higher than 1 µM [15]. Interestingly, lower nicotine concentrations (<1 µM) might also stimulate proliferation of different ECs [13], [15], [25]. The difference in the experimental conditions, particularly initial cell seeding densities, could help explain the variable results of different studies. In particular, a recent study showed that HUVEC proliferation depends highly on the cell seeding density, and even a small increase of cell density might inhibit proliferation [26]. The diversity of nicotine effects might also be explained by the fact that ECs express a variety of nicotinic acetylcholine receptors which might differently regulate various cellular functions [27].
We further investigated the effect of nicotine on the expression of several factors associated with inflammation, namely ICAM-1, VCAM-1, E-selectin, MCP-1, and IL-8, in the presence and absence of P. gingivalis LPS, which was used to model the conditions of periodontal inflammation. An increased expression of adhesion molecules in ECs is tightly associated with the progression of atherosclerosis [28]. In particular, E-selectin mediates the “rolling” of leukocytes along the endothelium, which is the reversible first interaction between endothelial and immune cells, whereas ICAM-1 and VCAM-1 are involved in the firm attachment of leukocytes to the endothelium and trans-endothelial migration [29]. MCP-1 and IL-8 are chemoattractants that induce the migration of neutrophils and monocytes, respectively, to the site of inflammation and promote the development of acute inflammation [30], [31]. In this study, nicotine had no effect on the expression of any pro-inflammatory mediators in the absence of P. gingivalis LPS. A recent study showed that nicotine at concentrations of 100 µg/ml (∼0.62 mM) had no effect on the on the production of IL-8 by HUVECs and slightly inhibited MCP-1 production [24]. Another study found that mRNA expression levels of VCAM-1 in human coronary artery ECs were slightly increased by a factor of about 1.6 in response to stimulation with 10-µM nicotine [32]. Finally, the surface expression of ICAM-1 and VCAM-1 in HUVECs was slightly increased by stimulation with 10-µM nicotine [33]. Thus, it might be concluded that the expression of pro-inflammatory mediators in HUVECs is only slightly—if at all—influenced by nicotine.
Stimulation of HUVECs with P. gingivalis LPS resulted in a significant increase in the expression of all pro-inflammatory mediators. This was observed at both mRNA and protein levels and is in agreement with previous reports [16]–[19], [22], [34]. The maximal response to P. gingivalis LPS was observed 4 h after stimulation, which is also in agreement with previous studies showing that maximal response of ECs to LPS is usually within several hours after stimulation [16], [35]–[37]. It should be also considered that, at the late stages, the autocrine response of HUVECs to produce cytokines might play an important role and interfere with the reaction to LPS. We found that nicotine in concentrations of 10 µM-1 mM did not influence the response of HUVECs to P. gingivalis LPS. However, nicotine at a concentration of 10 mM significantly decreased the expression of pro-inflammatory mediators induced by P. gingivalis LPS stimulation, which could be related to nicotine cytotoxicity. Interestingly, no significant effect of 10-mM nicotine on the expression of adhesion molecules was found in the absence of P. gingivalis LPS stimulation (Fig. 3). Therefore, one can assume that nicotine could influence pro-inflammatory pathways in HUVECs, which are activated upon P. gingivalis LPS stimulation. The effect of nicotine on the inflammatory response in HUVECs was also previously investigated. Patton et al showed that pre-incubation of human coronary artery ECs with 1-µM nicotine reduced the expression of IL-8 and MCP-1 in response to LPS [38]. Similarly, Saeed et al showed that nicotine in micromolar concentrations inhibited the expression of ICAM-1 in human microvascular ECs in response to stimulation with tumor necrosis factor α [39]. In contrast to these studies, we observed that only millimolar concentrations of nicotine were able to diminish inflammatory response of HUVECs to LPS. The reason for this discrepancy is not clear. Theoretically, it could be due to heterogeneity in the expression of nicotine receptors in different ECs [27], but this question needs to be investigated further.
Migration of ECs is an important process involved in angiogenesis and wound healing. We found that nicotine at concentrations of 1–10 mM inhibited EC migration in the presence and absence of P. gingivalis. The inhibitory effect of 10-mM nicotine on HUVEC migration could be at least partially explained by nicotine cytotoxicity. However, 1-mM nicotine was not cytotoxic as it did not affect HUVEC viability and apoptosis. Previous studies reported that nicotine at a concentration of about 1 µM stimulated EC migration [13], [40], [41]. Another study showed that nicotine at a concentration of 20 µg/ml (∼123.2 µM) had no effect on EC migration [42], which is in agreement with our observations. We can thereby conclude that the effect of nicotine on EC migration depends on its concentration.
Nicotine is the major component of tobacco smoke, and its presence in the body fluids of smokers is significantly increased compared to non-smokers. Previous studies showed that the serum levels of nicotine in smokers achieve near a 1-µM concentration [43]. In contrast, nicotine levels in the saliva of smokers may reach millimolar concentrations [44]. Similar nicotine levels were also assumed to be in respiratory system tissues of smokers [45]. Our study showed that inhibition of HUVEC proliferation, migration, and inflammatory response is induced by millimolar concentrations of nicotine. Therefore, it seems that the effects described in the present study might be physiologically important for the oral cavity but not as much on the systemic level.
A decrease of EC proliferation and migration in vitro might suggest less vascularization and impaired wound healing in vivo, which is supported by numerous clinical studies (for review, see [46]). For mimicking inflammation in vitro, we stimulated HUVECs with P. gingivalis LPS. Under these conditions, nicotine in millimolar concentrations attenuated the inflammatory response of HUVECs. A decreased release of chemoattractants MCP-1 and IL-8 following nicotine stimulation might be associated with a decreased requirement to attract leukocytes to sites of inflammation. Similarly, a decreased expression of adhesion molecules ICAM-1, VCAM-1, and E-selectin might be associated with decreased infiltration into the periodontal tissue. Thus, our data suggest that nicotine might decrease periodontal inflammation in vivo. This is supported by clinical studies showing that smoking periodontal patients have a decreased inflammatory response and gingival bleeding compared to non-smoking patients (for review, see [47], [48]).
In conclusion, our data show that the functional properties of ECs are affected by millimolar concentrations of nicotine, which are similar to that observed in the oral cavity of smokers. In contrast, micromolar concentrations of nicotine, which are usually present in the serum of smokers, had no influence on the functional properties of ECs. Nicotine at millimolar concentrations inhibited proliferation and migration of ECs as well as their response to periodontal pathogens. These effects of nicotine might be associated with decreased bleeding indices observed in smoking periodontitis patient.
Acknowledgments
The authors would like to thank Mrs. Nguyen Phuong Quynh and Mrs. Hedwig Rutschek (both Medical University of Vienna) for excellent technical assistances.
Author Contributions
Conceived and designed the experiments: NA OA XR. Performed the experiments: NA OA YT. Analyzed the data: NA OA FF XO XR. Contributed reagents/materials/analysis tools: HB XR. Wrote the paper: NA OA FF HB XO XR.
References
- 1. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr (1998) Microbial complexes in subgingival plaque. J Clin Periodontol 25: 134–144.
- 2. Socransky SS, Haffajee AD (1992) The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 63: 322–331.
- 3. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, et al. (2012) Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 125: 2520–2544.
- 4. Johnson GK, Guthmiller JM (2007) The impact of cigarette smoking on periodontal disease and treatment. Periodontol 2000 44: 178–194.
- 5. Bergstrom J, Persson L, Preber H (1988) Influence of cigarette smoking on vascular reaction during experimental gingivitis. Scand J Dent Res 96: 34–39.
- 6. Mavropoulos A, Brodin P, Rosing CK, Aass AM, Aars H (2007) Gingival blood flow in periodontitis patients before and after periodontal surgery assessed in smokers and non-smokers. J Periodontol 78: 1774–1782.
- 7. Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340: 115–126.
- 8. Pepine CJ (1998) Clinical implications of endothelial dysfunction. Clin Cardiol 21: 795–799.
- 9. Quyyumi AA (1998) Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105: 32S–39S.
- 10. Moughal NA, Adonogianaki E, Thornhill MH, Kinane DF (1992) Endothelial cell leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression in gingival tissue during health and experimentally-induced gingivitis. J Periodontal Res 27: 623–630.
- 11. Gemmell E, Walsh LJ, Savage NW, Seymour GJ (1994) Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res 29: 46–53.
- 12. Paoletti R, Gotto AM Jr, Hajjar DP (2004) Inflammation in atherosclerosis and implications for therapy. Circulation 109: III20–26.
- 13. Park YJ, Lee T, Ha J, Jung IM, Chung JK, et al. (2008) Effect of nicotine on human umbilical vein endothelial cells (HUVECs) migration and angiogenesis. Vascul Pharmacol 49: 32–36.
- 14. Heeschen C, Weis M, Cooke JP (2003) Nicotine promotes arteriogenesis. J Am Coll Cardiol 41: 489–496.
- 15. Villablanca AC (1998) Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84: 2089–2098.
- 16. Khlgatian M, Nassar H, Chou HH, Gibson FC 3rd, Genco CA (2002) Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70: 257–267.
- 17. Nakamura N, Yoshida M, Umeda M, Huang Y, Kitajima S, et al. (2008) Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 196: 59–67.
- 18. Honda T, Oda T, Yoshie H, Yamazaki K (2005) Effects of Porphyromonas gingivalis antigens and proinflammatory cytokines on human coronary artery endothelial cells. Oral Microbiol Immunol 20: 82–88.
- 19. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S (2009) Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res 88: 741–745.
- 20. Andrukhov O, Andrukhova O, Hulan U, Tang Y, Bantleon HP, et al. (2014) Both 25-hydroxyvitamin-d3 and 1,25-dihydroxyvitamin-d3 reduces inflammatory response in human periodontal ligament cells. PLoS ONE 9: e90301.
- 21.
Andrukhov O, Steiner I, Liu S, Bantleon HP, Moritz A, et al.. (2013) Different effects of Porphyromonas gingivalis lipopolysaccharide and TLR2 agonist Pam3CSK4 on the adhesion molecules expression in endothelial cells. Odontology.
- 22.
Andrukhov O, Ertlschweiger S, Moritz A, Bantleon HP, Rausch-Fan X (2013) Different effects of P. gingivalis LPS and E. coli LPS on the expression of interleukin-6 in human gingival fibroblasts. Acta Odontol Scand.
- 23. Qu Z, Laky M, Ulm C, Matejka M, Dard M, et al. (2010) Effect of Emdogain on proliferation and migration of different periodontal tissue-associated cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109: 924–931.
- 24. Allam E, Delacruz K, Ghoneima A, Sun J, Windsor L (2012) Effects of tobacco on cytokine expression from human endothelial cells. Oral Dis 19: 660–665.
- 25. Li XW, Wang H (2006) Non-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularization. Life Sci 78: 1863–1870.
- 26. Heng BC, Bezerra PP, Preiser PR, Law SK, Xia Y, et al. (2011) Effect of cell-seeding density on the proliferation and gene expression profile of human umbilical vein endothelial cells within ex vivo culture. Cytotherapy 13: 606–617.
- 27. Wu JC, Chruscinski A, De Jesus Perez VA, Singh H, Pitsiouni M, et al. (2009) Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J Cell Biochem 108: 433–446.
- 28. Libby P (2000) Changing concepts of atherogenesis. J Intern Med 247: 349–358.
- 29. Lusis AJ (2000) Atherosclerosis. Nature 407: 233–241.
- 30. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv Immunol 55: 97–179.
- 31. Silva TA, Garlet GP, Fukada SY, Silva JS, Cunha FQ (2007) Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 86: 306–319.
- 32. Zhang S, Day I, Ye S (2001) Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis 154: 277–283.
- 33. Albaugh G, Bellavance E, Strande L, Heinburger S, Hewitt CW, et al. (2004) Nicotine induces mononuclear leukocyte adhesion and expression of adhesion molecules, VCAM and ICAM, in endothelial cells in vitro. Ann Vasc Surg 18: 302–307.
- 34. Nassar H, Chou HH, Khlgatian M, Gibson FC 3rd, Van Dyke TE, et al. (2002) Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70: 268–276.
- 35. Takahashi Y, Davey M, Yumoto H, Gibson FC 3rd, Genco CA (2006) Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell Microbiol 8: 738–757.
- 36. Eppihimer MJ, Russell J, Anderson DC, Wolitzky BA, Granger DN (1997) Endothelial cell adhesion molecule expression in gene-targeted mice. Am J Physiol 273: H1903–1908.
- 37. Lubos E, Mahoney CE, Leopold JA, Zhang YY, Loscalzo J, et al. (2010) Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression. Faseb J 24: 2525–2532.
- 38. Patton GW, Powell DA, Hakki A, Friedman H, Pross S (2006) Nicotine modulation of cytokine induction by LPS-stimulated human monocytes and coronary artery endothelial cells. Int Immunopharmacol 6: 26–35.
- 39. Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, et al. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201: 1113–1123.
- 40. Park HS, Cho K, Park YJ, Lee T (2011) Chronic nicotine exposure attenuates proangiogenic activity on human umbilical vein endothelial cells. J Cardiovasc Pharmacol 57: 287–293.
- 41. Ng MK, Wu J, Chang E, Wang BY, Katzenberg-Clark R, et al. (2007) A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 27: 106–112.
- 42. Snajdar RM, Busuttil SJ, Averbook A, Graham DJ (2001) Inhibition of endothelial cell migration by cigarette smoke condensate. J Surg Res 96: 10–16.
- 43. Russell MA, Jarvis M, Iyer R, Feyerabend C (1980) Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J 280: 972–976.
- 44. Feyerabend C, Higenbottam T, Russell MA (1982) Nicotine concentrations in urine and saliva of smokers and non-smokers. Br Med J (Clin Res Ed) 284: 1002–1004.
- 45. Seow WK, Thong YH, Nelson RD, MacFarlane GD, Herzberg MC (1994) Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 18: 119–127.
- 46. Chambrone L, Chambrone D, Pustiglioni FE, Chambrone LA, Lima LA (2009) The influence of tobacco smoking on the outcomes achieved by root-coverage procedures: a systematic review. J Am Dent Assoc 140: 294–306.
- 47. Rivera-Hidalgo F (2003) Smoking and periodontal disease. Periodontol 2000 32: 50–58.
- 48. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, et al. (2006) The effect of smoking on periodontal treatment response: a review of clinical evidence. J Clin Periodontol 33: 241–253.